Emergent BioSolutions Inc. (EBS) › Net IncomeEmergent BioSolutions Inc. (EBS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: $31.14M2010: $51.70M2011: $23.02M2012: $23.52M2013: $31.14M2014: $36.74M2015: $62.87M2016: $51.80M2017: $82.60M2018: $62.70M2019: $54.50M2020: $305.80M2021: $219.50M2022: -$211.60M2023: -$760.50M2024: -$190.60M2025: $52.60M$52.60M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$52.60M+127.6%2024-$190.60M+74.9%2023-$760.50M-259.4%2022-$211.60M-196.4%2021$219.50M-28.2%2020$305.80M+461.1%2019$54.50M-13.1%2018$62.70M-24.1%2017$82.60M+59.5%2016$51.80M-17.6%2015$62.87M+71.1%2014$36.74M+18.0%2013$31.14M+32.4%2012$23.52M+2.2%2011$23.02M-55.5%2010$51.70M+66.0%2009$31.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share